KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Other Non-Current Assets (2016 - 2025)

Novavax (NVAX) has 16 years of Other Non-Current Assets data on record, last reported at $87.5 million in Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 264.62% year-over-year to $87.5 million; the TTM value through Dec 2025 reached $87.5 million, up 264.62%, while the annual FY2025 figure was $87.5 million, 264.62% up from the prior year.
  • Other Non-Current Assets reached $87.5 million in Q4 2025 per NVAX's latest filing, down from $107.7 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $107.7 million in Q3 2025 and bottomed at $1.5 million in Q2 2021.
  • Average Other Non-Current Assets over 5 years is $31.7 million, with a median of $29.5 million recorded in 2022.
  • Peak YoY movement for Other Non-Current Assets: plummeted 60.27% in 2021, then surged 1213.83% in 2022.
  • A 5-year view of Other Non-Current Assets shows it stood at $24.3 million in 2021, then grew by 17.2% to $28.5 million in 2022, then increased by 23.5% to $35.2 million in 2023, then crashed by 31.74% to $24.0 million in 2024, then soared by 264.62% to $87.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $87.5 million in Q4 2025, $107.7 million in Q3 2025, and $21.4 million in Q2 2025.